Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02649426 · ClinicalTrials.gov registry record · NA
A Study of the ReCor Medical Paradise System in Clinical Hypertension
A NA study of Hypertension and Vascular Diseases, sponsored by ReCor Medical.
- Active
- Registry status
- NA
- Development phase
- 282
- Enrollment target
- 20
- Study locations
NCT02649426 is a NA study of Hypertension and Vascular Diseases that is active but no longer recruiting, run by ReCor Medical. The registered enrollment target is 282 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (92% lower). The trial reports 20 study locations across 16 states.
The verdict
NCT02649426, a NA study of Hypertension and Vascular Diseases, is active but no longer recruiting, sponsored by ReCor Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 282 participants
- Enrollment target
- 20
- Study locations
Study Summary
RADIANCE-HTN is a randomized, double-blind, sham controlled, 2-cohort study (TRIO and SOLO) designed to demonstrate efficacy and document the safety of the Paradise Renal Denervation System in two distinct populations of hypertensive subjects.
Conditions Studied
Interventions
- DEVICE Sham Procedure
- DEVICE The Paradise® Renal Denervation Ultrasound System
Study Locations (20)
California
- Cedars-Sinai Medical Center - Los Angeles
- Sutter Health Medical Center - Sacramento
Massachusetts
- Massachusetts General Hospital - Boston
- The Brigham and Women's Hospital - Boston
New York
- New York University School of Medicine - New York
- Columbia University / NewYork Presbyterian Hospital - New York
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
- Cleveland Clinic - Cleveland
Alabama
- University of Alabama at Birmingham - Birmingham
Connecticut
- Stamford Hospital - Stamford
Florida
- The Cardiac and Vascular Institute - Gainesville
Georgia
- Emory University Hospital Midtown - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 282 participants |
| Start Date | 2016-03 |
| Est. Completion | 2025-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02649426
The ClinicalTrials.gov registry entry for NCT02649426 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 282 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (92% lower). The listed sponsor is ReCor Medical, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Sham Procedure is the first listed.
NCT02649426 reports 20 study locations spanning 16 distinct geographic areas - top geographies include California, Massachusetts, New York.
Frequently Asked Questions
What is clinical trial NCT02649426 about?
NCT02649426 is a clinical study titled "A Study of the ReCor Medical Paradise System in Clinical Hypertension". RADIANCE-HTN is a randomized, double-blind, sham controlled, 2-cohort study (TRIO and SOLO) designed to demonstrate efficacy and document the safety of the Paradise Renal Denervation System in two distinct populations of hypertensive subjects.
What is the current status of trial NCT02649426?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 282 participants. The study started on 2016-03. Estimated completion is 2025-05.
What conditions does trial NCT02649426 study?
This clinical trial studies the following conditions: Hypertension, Vascular Diseases.
What interventions are being tested in trial NCT02649426?
The interventions under investigation include: Sham Procedure (DEVICE), The Paradise® Renal Denervation Ultrasound System (DEVICE).
Who is sponsoring clinical trial NCT02649426?
This trial is sponsored by ReCor Medical, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02649426 being conducted?
This trial has 20 study locations across Alabama, California, Connecticut, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.